JD Health International Inc. (06618) has released its monthly return on movements in securities for the period ended 31 January 2026. The authorized share capital remained at 100,000,000,000 ordinary shares, each with a par value of USD 0.0000005, totaling USD 50,000. The total number of issued shares stayed at 3,209,275,111, with no changes to issued or treasury shares.

Public float requirements were confirmed to be met at the close of January. Under the Pre-IPO ESOP, share options outstanding decreased from 11,322,575 to 11,193,440 after partial exercises and lapses; no new shares were issued because those options were settled using previously issued shares held by a trustee. The Post-IPO Share Option Scheme still has a capacity of 312,708,211 shares that may be issued upon full exercise, while the Post-IPO Share Award Scheme can potentially issue 16,692,802 shares. No other share repurchases, conversions, or new issuances took place during the month.